The Amiodarone Hydrochloride API Market is a critical segment of the global antiarrhythmic sector, with the broader tablet market valued at $12.32 billion in 2026. Amiodarone remains a "National Essential Medicine" due to its unrivaled efficacy in treating life-threatening ventricular arrhythmias and atrial fibrillation. The market is currently expanding at a 11.57% CAGR, driven by an aging...